Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Integrated BioTherapeutics focuses on the discovery of novel vaccines and therapeutics for emerging infectious diseases.
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs
Truly Technologies develops biospecimen processing technologies for diagnostic, therapeutic and life science research applications.
Iaso Therapeutics develops vaccines to improve human health and cure diseases.
InDevR develops and manufactures microarray technologies as well as novel solutions to support the life science industry.
Kovina Therapeutics operates as a pre-clinical biotechnology company.
IBBR is leverages state-of-art integrative methods for bioanalytical, biophysical and structural characterization of biomolecules.
Melax Technologies specializes in machine learning, software, domain, natural language processing and medical coding services.
Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Moonlight Therapeutics is focused on developing safe, effective, and patient-friendly treatments for food allergies.
Scanogen is a molecular diagnostic company.
Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
Sunflower Therapeutics is a biotech company that delivers next-generation protein manufacturing solutions.
MiNK Therapeutics is a biopharmaceutical company developing allogeneic iNKT cell therapies and immune technologies for treatment.
Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines
Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.
Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.
Acenxion Biosystems is a privately funded company developing automated medical diagnostic systems for precision medicine.
Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
Clairyon is a healthcare technology company that specializes in outpatient monitoring, predictive analytics, and quality reporting services.
TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.
Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
National Institute of Allergy and Infectious Diseases has invested in 64 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institute of Allergy and Infectious Diseases's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 21 different industry categories.
Among tracked funding rounds, InDevR received $9.0M in a Series B round. National Institute of Allergy and Infectious Diseases's total known invested capital is $399.1M.
National Institute of Allergy and Infectious Diseases's average investment size is $6.2M across its portfolio of 64 companies.
Recent National Institute of Allergy and Infectious Diseases portfolio additions include Integrated BioTherapeutics, Sapience Therapeutics, Truly Technologies, Iaso Therapeutics, InDevR. These companies were founded in 2020 or later.